LSIL lesion of the cervix uteri, vagina or vulva

N14_FEMALE_GENITAL_LSIL

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule only females	293373
2. Check conditions None	293373
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — N87.0, N89.0, N90.0 Hospital discharge: ICD-9 — 6221A\|0781C Cause of death: ICD-10 — N87.0, N89.0, N90.0 Cause of death: ICD-9 — 6221A\|0781C 2 out of 7 registries used, show all original rules.	6089
4. Check minimum number of events None	6089
5. Include endpoints None	6089
6. Filter based on genotype QC (FinnGen only)	6089

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF7

NAME	N14_FEMALE_GENITAL_LSIL
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	2
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	N870\|N890\|N900
HD_ICD_9	6221A\|0781C
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	N870\|N890\|N900
COD_ICD_9	6221A\|0781C
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to LSIL lesion of the cervix uteri, vagina or vulva based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	36492	36492	-
Only index persons	35540	35540	-
Unadjusted period prevalence (%)
Whole population	1.05	1.05	-
Only index persons	1.31	1.31	-
Median age at first event (years)
Whole population	-	35.02	-
Only index persons	-	34.91	-

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	6089	6089	-
Unadjusted period prevalence (%)	2.08	2.08	-
Median age at first event (years)	36.12	36.12	-

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5377: Matched controls
53769

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

ULA02

NOMESCO Finland

Kolposcopy

30.5

323.0

3925

4372

R87.6

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal cytological findings

24.6

323.0

3719

4485

N87.1

ICD-10 Finland

Moderate cervical dysplasia

9.8

323.0

707

817

LDC03

NOMESCO Finland

Conisation of cervix uteri using diathermy or laser

18.9

323.0

2006

1638

N89.0

ICD-10 Finland

Mild vaginal dysplasia

+∞

323.0

449

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

10.2

323.0

2954

5736

LDA10

NOMESCO Finland

Curettage of cervix uteri

12.8

323.0

1500

1583

LDA20

NOMESCO Finland

Biopsy of vaginal cervix

19.8

323.0

2851

2898

A63.0

ICD-10 Finland

Anogenital (venereal) warts

8.7

323.0

934

1269

N87.0

ICD-10 Finland

Mild cervical dysplasia

5973.6

323.0

4093

0781C

ICD-9 Finland

Other diseases due to viruses and Chlamydiae, Viral warts[CONDYLOMA ACCUMINATUM]

+∞

323.0

587

N90.0

ICD-10 Finland

Mild vulvar dysplasia

+∞

323.0

380

LEB00

NOMESCO Finland

Biopsy of vagina

13.5

293.3

530

431

LFB00

NOMESCO Finland

Biopsy of vulva or perineum

9.3

243.3

534

631

LDB20

NOMESCO Finland

Electrocoagulation or laser therapy of cervix uteri

14.3

190.7

334

248

N87.2

ICD-10 Finland

Severe cervical dysplasia, not elsewhere classified

6.1

182.4

530

940

6221A

ICD-9 Finland

Noninflammatory disorders of cervix, Dysplasia of cervix (uteri)[DYSPLASIA CERVICIS UTERI LEVIS]

+∞

180.2

172

LEB30

NOMESCO Finland

Destruction of lesion of vaginal mucosa

28.1

156.1

216

R87.5

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal microbiological findings

9.3

152.3

330

375

8474

FHL

Coagulation, excision, or biopsy of local change (eg, condyloma, tumor) in operating room or anesthesia

44.5

145.7

181

8325

FHL

Coagulation, cryo or laser in anesthesia or operating room

66.3

138.8

161

8077/2-C53.9

ICD-O-3

Squamous intraepithelial neoplasia, high grade of cervix uteri

6.7

136.5

369

589

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.9

106.9

2572

17508

G01AA10

ATC

clindamycin; vaginal

2.0

96.4

1485

8455

8411

FHL

Local change laser, coagulation, biopsy or removal

51.5

96.2

116

ZXC00

NOMESCO Finland

Use of diathermy

12.3

94.2

175

147

8326

FHL

Batch conization

23.0

92.6

135

N89.1

ICD-10 Finland

Moderate vaginal dysplasia

38.6

83.2

106

D06BB04

ATC

podophyllotoxin; topical

2.7

71.2

539

2141

N87.9

ICD-10 Finland

Dysplasia of cervix uteri, unspecified

12.4

61.1

112

R87.0

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal level of enzymes

47.9

58.4

D06BB10

ATC

imiquimod; topical

3.1

56.5

335

1135

N90.1

ICD-10 Finland

Moderate vulvar dysplasia

26.0

55.1

LFB20

NOMESCO Finland

Destruction of lesion of vulva or perineum

7.4

51.2

125

172

N89.2

ICD-10 Finland

Severe vaginal dysplasia, not elsewhere classified

25.5

48.5

R87.7

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal histological findings

10.0

47.1

8077/2-C52.9

ICD-O-3

Squamous intraepithelial neoplasia, high grade of vagina, NOS

38.4

45.0

J02AC01

ATC

fluconazole; systemic

1.5

44.5

2867

23252

X86

ICPC

Abnormal cervix smear

4.7

42.9

150

324

N90.2

ICD-10 Finland

Severe vulvar dysplasia, not elsewhere classified

16.6

42.9

LFB10

NOMESCO Finland

Excision of lesion of vulva or perineum

5.5

41.2

126

235

LDB10

NOMESCO Finland

Cryotherapy of cervix uteri

10.8

39.7

LCA06

NOMESCO Finland

Biopsy of endometrium

1.7

39.6

935

5894

C539, 6666, 0

ICD-O-3

4.4

39.0

145

334

A63.8

ICD-10 Finland

Other specified predominantly sexually transmitted diseases

18.4

38.7

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

37.9

1679

12410

P01AB01

ATC

metronidazole; oral, rectal

1.5

37.3

2317

18375

Z3231

NOMESCO Finland

Registered nurse

1.5

32.3

1222

8652

G01AF01

ATC

metronidazole; vaginal

1.7

31.0

676

4136

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.6

30.8

851

5566

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.5

30.5

1295

9393

N93.0

ICD-10 Finland

Postcoital and contact bleeding

4.7

27.7

208

Z2221

NOMESCO Finland

Medical doctor

1.4

27.2

1504

11463

B97.7

ICD-10 Finland

Papillomavirus as the cause of diseases classified to other chapters

9.2

26.4

8077/2-C51.9

ICD-O-3

Squamous intraepithelial neoplasia, high grade of vulva, NOS

21.2

26.0

Z3232

NOMESCO Finland

Midwife

1.6

24.6

786

5311

1390

FHL

Colposcopy

14.9

24.2

8111

FHL

Taking a biopsy from the mouth of the uterus at the operating room or under anesthesia (vulvabiopsia 8474, vaginabiopsia 8411)

13.0

22.8

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

1.6

22.8

720

4842

N72

ICD-10 Finland

Inflammatory disease of cervix uteri

4.3

22.6

196

N76.0

ICD-10 Finland

Acute vaginitis

1.7

22.5

494

3018

6221B

ICD-9 Finland

Noninflammatory disorders of cervix, Dysplasia of cervix (uteri)[DYSPLASIA CERVICIS UTERI MODERATA]

14.9

22.4

R2110

NOMESCO Finland

Giving the first information

1.7

21.1

469

2870

TLC02

NOMESCO Finland

Simple extraction of IUD

1.8

20.0

365

2102

X23

ICPC

Fear sexually transm dis female

1.7

19.8

391

2311

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.9

19.7

297

1605

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

19.0

1424

11305

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

19.0

3540

32002

R87.9

ICD-10 Finland

Abnormal findings in specimens from female genital organs, unspecified abnormal finding

7.1

18.5

LFC00

NOMESCO Finland

Partial excision of vulva

8.7

18.3

N02AX02

ATC

tramadol; systemic, rectal

1.3

18.2

1680

13741

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

18.2

1124

8631

L90.0

ICD-10 Finland

Lichen sclerosus et atrophicus

2.4

17.9

155

661

SPAT1193

SPAT

Pap smear

1.4

17.4

804

5847

N87

ICD-10 Finland

Dysplasia of cervix uteri

16.0

17.0

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.4

16.5

815

6001

LDC00

NOMESCO Finland

Conisation of cervix uteri using knife

11.6

16.5

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.6

16.1

471

3101

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

15.9

2947

26281

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

1.6

15.6

379

2377

M03BX02

ATC

tizanidine; oral

1.3

15.4

3289

29792

M54.5

ICD-10 Finland

Low back pain

1.3

15.3

1614

13378

8113

FHL

Fractional scraping

1.9

15.2

228

1231

J01AA02

ATC

doxycycline; systemic

1.3

14.7

3856

35705

N07BA03

ATC

varenicline; oral

1.8

14.7

253

1432

X92

ICPC

Chlamydia infection genital female

2.7

14.5

365

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

14.4

288

1712

7950A

ICD-9 Finland

Nonspecific abnormal histological and immunological findings, Nonspecific abnormal Papanicolaou smear of cervix

12.6

14.3

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.3

14.2

3021

27211

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.3

14.2

1880

16012

J01DB01

ATC

cefalexin; oral

1.3

14.0

4189

39304

J01CA08

ATC

pivmecillinam; oral

1.2

13.8

2598

23038

WX110

NOMESCO Finland

Local anesthesy

1.3

13.7

3551

32657

J05AB01

ATC

aciclovir; systemic

1.3

13.6

1068

8465

N02BE01

ATC

paracetamol; systemic, rectal

1.3

13.5

4291

40442

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

13.3

1887

16165

LCH11

NOMESCO Finland

Pharmacologic abortion

1.6

13.3

318

1987

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

13.3

3761

34875

J01EA01

ATC

trimethoprim; systemic

1.3

13.3

1324

10849

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

13.3

1714

14518

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

13.2

1842

15742

SPAT1308

SPAT

Sexual health counselling

1.3

13.2

913

7098

ZXC10

NOMESCO Finland

Use of laser

2.5

13.2

101

405

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.5

13.0

448

3062

X15

ICPC

Vaginal symptom/complaint other

1.7

12.9

245

1432

L04AX01

ATC

azathioprine; systemic

1.8

12.9

206

1139

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

12.8

2107

18342

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

12.7

2090

18190

R87.2

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal level of other drugs, medicaments and biological substances

6.8

12.6

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.2

12.5

2121

18509

TLW99

NOMESCO Finland

Other minor surgical procedure in gynaecology

2.1

12.5

136

651

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

12.2

2479

22046

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.2

12.2

2688

24114

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

12.2

1951

16904

XLA10

NOMESCO Finland

1.6

12.1

323

2074

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.4

11.9

528

3796

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

3.5

11.8

156

8070/2-C53.9

ICD-O-3

Squamous cell carcinoma in situ, NOS, of cervix uteri

4.5

11.7

J05AB11

ATC

valaciclovir; oral

1.4

11.7

627

4671

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.3

11.4

1417

11902

N30.0

ICD-10 Finland

Acute cystitis

1.4

11.4

663

5002

R87.1

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal level of hormones

7.8

11.3

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.3

11.3

1041

8418

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

11.2

395

2708

Z01.2

ICD-10 Finland

Dental examination

1.2

11.1

2095

18417

N03AX16

ATC

pregabalin; oral

1.3

11.1

943

7537

SDA02

NOMESCO Finland

Parodonthologic therapy

1.2

11.1

1631

13959

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

11.1

4818

46437

ULC02

NOMESCO Finland

Hysteroscopy

1.6

11.0

312

2040

J01DA01

ATC

[U] cefalexin; systemic

1.2

10.9

3145

28858

A02BC02

ATC

pantoprazole; systemic

1.2

10.7

2886

26275

UJF32

NOMESCO Finland

Coloscopy

1.3

10.5

873

6952

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

10.4

2557

23035

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.4

10.4

657

5021

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.4

10.4

487

3536

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

1.3

10.4

1125

9275

N06AB04

ATC

citalopram; systemic

1.3

10.1

1006

8201

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

1.7

10.1

210

1266

G01AF04

ATC

miconazole; vaginal

1.5

10.1

308

2048

8077/2-C53.1

ICD-O-3

Squamous intraepithelial neoplasia, high grade of exocervix

6.9

10.1

D82

ICPC

Teeth/gum disease

1.2

10.0

1784

15543

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.2

10.0

2746

24971

O34.4

ICD-10 Finland

Maternal care for other abnormalities of cervix

6.1

10.0

6221C

ICD-9 Finland

Noninflammatory disorders of cervix, Dysplasia of cervix (uteri)[DYSPLASIA CERVICIS UTERI GRAVIS]

7.0

9.8

K02.1

ICD-10 Finland

Caries of dentine

1.2

9.6

2936

26918

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.3

9.6

1192

9977

Z30.0

ICD-10 Finland

General counselling and advice on contraception

1.4

9.6

428

3081

8339

FHL

Other measure in this category

6.3

9.5

D19

ICPC

Teeth/gum symptom/complaint

1.2

9.4

1277

10790

N06AX11

ATC

mirtazapine; oral

1.2

9.3

1397

11937

K05.31

ICD-10 Finland

Periodontitis pronounced

1.5

9.3

291

1947

N73.9

ICD-10 Finland

Female pelvic inflammatory disease, unspecified

1.9

9.2

123

643

SFA00

NOMESCO Finland

Small filling

1.4

9.1

563

4286

LCA13

NOMESCO Finland

Curettage of cervix and body of uterus

1.6

9.1

251

1631

LDB00

NOMESCO Finland

Excision of lesion of cervix uteri

2.2

9.0

389

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

8.9

302

2058

Z01.8

ICD-10 Finland

Other specified special examinations

1.3

8.9

864

7016

D06.1

ICD-10 Finland

Carcinoma in situ: Exocervix

4.6

8.9

N05CF01

ATC

zopiclone; oral

1.2

8.8

1203

10161

N90.9

ICD-10 Finland

Noninflammatory disorder of vulva and perineum, unspecified

3.1

8.8

144

N05BA04

ATC

oxazepam; oral

1.2

8.8

1108

9276

D06.0

ICD-10 Finland

Carcinoma in situ: Endocervix

3.6

8.8

102

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

6.3

8.8

A05

ICPC

Feeling ill

1.5

8.7

255

1679

8112

FHL

Scraping the cervix

7.2

8.7

J01MA02

ATC

ciprofloxacin; systemic

1.2

8.6

1427

12310

J01FF01

ATC

clindamycin; systemic

1.2

8.5

1123

9445

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.2

8.5

1780

15697

D07AD01

ATC

clobetasol; topical

1.3

8.5

619

4835

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.4

8.5

441

3264

6230A

ICD-9 Finland

Noninflammatory disorders of vagina, Dysplasia of vagina[DYSPLASIA VAGINAE LEVIS]

90.2

8.4

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

8.4

932

7686

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

8.4

1879

16673

C51.11

ICD-10 Finland

Squamous cell carcinoma of the labium minus

12.8

8.4

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.3

8.3

545

4187

ZXA00

NOMESCO Finland

Right side

1.3

8.3

874

7164

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

8.3

3571

33543

WX290

NOMESCO Finland

Other blockade of nerve

1.2

8.3

2374

21525

J02AC02

ATC

itraconazole; systemic

1.3

8.2

834

6802

P01BA02

ATC

hydroxychloroquine; oral

1.4

8.2

361

2592

Z71.8

ICD-10 Finland

Other specified counselling

1.2

8.2

1157

9799

ZXE00

NOMESCO Finland

One hour or less

1.2

8.2

1864

16548

N90.3

ICD-10 Finland

Dysplasia of vulva, unspecified

14.5

8.2

M79.6

ICD-10 Finland

Pain in limb

1.2

8.2

1583

13844

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.4

8.2

419

3093

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.4

8.1

453

3391

P01

ICPC

Feeling anxious/nervous/tense

1.3

8.1

593

4630

D07.1

ICD-10 Finland

Carcinoma in situ: Vulva

11.7

8.1

M25.5

ICD-10 Finland

Pain in joint

1.2

8.0

1364

11774

Z30.2

ICD-10 Finland

Sterilization

1.3

8.0

642

5077

R74

ICPC

Upper respiratory infection acute

1.2

8.0

1654

14554

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.2

8.0

1445

12555

LEB10

NOMESCO Finland

Excision of lesion of vagina

3.3

7.9

112

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.2

7.9

1386

12007

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.3

7.8

310

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.5

7.8

250

1685

Z2446

NOMESCO Finland

Social worker

1.5

7.8

244

1635

A56.0

ICD-10 Finland

Chlamydial infection of lower genitourinary tract

2.0

7.8

487

M01AE02

ATC

naproxen; oral, rectal

1.2

7.8

2816

25985

L04AA01

ATC

[U] ciclosporin; systemic

2.4

7.7

262

N93.9

ICD-10 Finland

Abnormal uterine and vaginal bleeding, unspecified

1.8

7.7

137

791

7020X

ICD-9 Finland

Other dermatoses, Actinic keratosis[DERMATOSES PRAECANCEROSAE ALIAE]

45.0

7.7

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.3

7.6

856

7060

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

1.6

7.6

195

1246

N95.0

ICD-10 Finland

Postmenopausal bleeding

1.4

7.6

317

2256

ZX120

NOMESCO Finland

Intravenous

1.4

7.6

327

2343

A60.0

ICD-10 Finland

Herpesviral infection of genitalia and urogenital tract

1.8

7.6

117

648

8070/3-C51.9

ICD-O-3

Squamous cell carcinoma, NOS, of vulva, NOS

10.0

7.5

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.3

7.5

723

5859

WX002

NOMESCO Finland

Sedation and analgesia

1.3

7.5

661

5300

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.4

7.4

326

2346

WZA90

NOMESCO Finland

Other doctors statement

1.2

7.3

994

8374

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.4

7.3

396

2951

K50.8

ICD-10 Finland

Other Crohn disease

2.2

7.3

335

Z20.2

ICD-10 Finland

Contact with and exposure to infections with a predominantly sexual mode of transmission

1.7

7.3

133

777

ZXA10

NOMESCO Finland

Bilateral

1.3

7.2

629

5025

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.2

7.2

1221

10521

W11

ICPC

Contraception oral

1.3

7.2

545

4277

Z00.0

ICD-10 Finland

General medical examination

1.3

7.2

673

5430

N02AJ06

ATC

codeine and paracetamol; systemic

1.2

7.2

1604

14180

R51.80

ICD-10 Finland

Headache

1.3

7.2

738

6026

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.4

7.2

339

2471

7100A

ICD-9 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

7.9

7.1

JAH01

NOMESCO Finland

Laparoscopy

1.5

7.0

241

1653

M54.4

ICD-10 Finland

Lumbago with sciatica

1.3

6.9

702

5720

N77.1*A60.0

ICD-10 Finland

Vaginitis, vulvitis and vulvovaginitis in herpesviral [herpes simplex] infection

2.8

6.9

153

K05.30

ICD-10 Finland

Periodontitis complex

1.4

6.9

395

2975

Z3226

NOMESCO Finland

Physiotherapist

1.3

6.9

686

5578

M79.1

ICD-10 Finland

Myalgia

1.3

6.9

588

4689

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.5

6.8

203

1347

N05AH04

ATC

quetiapine; oral

1.3

6.8

724

5932

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.2

6.8

1157

9973

Z30.1

ICD-10 Finland

Insertion of (intrauterine) contraceptive device

1.2

6.8

886

7433

SPAT1283

SPAT

Restricted health certificate

1.2

6.7

1128

9703

KMAK

NOMESCO Finland

1.2

6.7

2807

26061

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.3

6.7

511

4014

WX408

NOMESCO Finland

General anesthesy, balanced

1.2

6.7

1031

8795

N90.4

ICD-10 Finland

Leukoplakia of vulva

3.7

6.6

M32.0

ICD-10 Finland

Drug-induced systemic lupus erythematosus

5.1

6.6

6350C

ICD-9 Finland

Legally induced abortion, Complicated by genital tract and pelvic infection[ABORTUS PROV LEGAL SINE COMPL,SOSIAALISET SYYT]

1.4

6.6

286

2054

M03BC51

ATC

orphenadrine, combinations; systemic

1.2

6.6

1358

11906

D06BB03

ATC

aciclovir; topical

1.5

6.6

218

1486

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.7

6.6

130

780

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

1.6

6.5

166

1065

C07AA05

ATC

propranolol; systemic

1.2

6.5

951

8069

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1.6

6.5

165

1057

G44.2

ICD-10 Finland

Tension-type headache

1.3

6.5

669

5468

TPH04

NOMESCO Finland

Cathetrisation of vein

1.3

6.4

687

5634

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.3

6.4

613

4961

NOMESCO Finland

7.4

6.4

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.3

6.4

474

3711

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.3

6.4

371

2804

K03.64

ICD-10 Finland

Dental calculus supragingival

1.2

6.3

1417

12504

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.3

6.3

558

4473

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.5

6.3

180

1189

R4110

NOMESCO Finland

Physiotherapy

1.2

6.3

959

8173

N90.8

ICD-10 Finland

Other specified noninflammatory disorders of vulva and perineum

2.2

6.2

246

TQW40

NOMESCO Finland

Remowal of suture of skin

1.4

6.2

241

1692

H02AB06

ATC

prednisolone; systemic

1.2

6.2

1967

17842

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

3.1

6.2

100

N86

ICD-10 Finland

Erosion and ectropion of cervix uteri

3.2

6.2

8511

FHL

Cervical dilation and drainage with suction

1.5

6.2

188

1259

127

Kela drug reimbursment

Transplant complication

2.5

6.1

184

R05

ICPC

Cough

1.2

6.1

969

8283

A02BC03

ATC

lansoprazole; oral

1.2

6.1

1094

9461

L03

ICPC

Low back symptom/complaint

1.2

6.1

1049

9043

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

6.0

1126

9774

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.3

6.0

609

4962

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1337

3420

4.73

307.65

2.3

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

3255

16370

3.12

307.65

2.4

1.5

—

(3025130) Human papilloma virus identified in Specimen

1044

1361

9.05

307.65

2.5

1.6

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

341

403

8.90

267.54

2.7

1.7

—

(40768804) Tissue Pathology biopsy report

3383

22794

2.09

167.22

2.7

2.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1598

10182

1.77

76.42

2.3

1.9

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1744

11458

1.73

74.54

2.4

2.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

939

5855

1.71

45.57

1.9

1.6

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1143

7628

1.61

42.30

2.1

1.8

—

(4035726)

624

3961

1.64

27.42

1.3

1.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

906

6480

1.47

23.01

2.8

2.5

e6/l

4.5

4.7

0.22

488

3292

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

934

6992

1.40

18.10

2.6

2.3

e6/l

1.1

1.2

0.23

513

3777

(3031040) Bacteria [#/volume] in Urine by Automated count

3800

34502

1.27

17.19

4.4

4.0

e6/l

1054.6

2126.4

0.87

376

(3013707) Erythrocyte sedimentation rate by Westergren method

4180

38401

1.28

17.16

4.3

3.8

mm/h

10.1

10.3

0.28

3960

36198

(3017143) Hepatitis C virus Ab [Presence] in Serum

1023

7887

1.36

16.39

1.7

1.6

—

(3018095) Leukocytes [#/volume] in Urine

1951

16433

1.28

16.39

3.9

3.2

e6/l

66.0

77.1

0.61

1305

10785

(36304419) Bacteria [Presence] in Urine

1462

11872

1.30

16.32

3.0

2.6

—

(3037467) Urinalysis macro (dipstick) panel - Urine

3921

35833

1.26

16.30

4.5

4.0

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1441

11688

1.31

16.21

3.6

3.4

—

(40758558) Short blood count panel - Blood

1542

12664

1.29

15.70

6.9

6.5

—

(3002582) Erythrocytes [#/volume] in Urine

1574

12988

1.29

15.39

3.2

2.8

e6/l

30.8

76.1

2.61

1169

9708

(3001604) Monocytes [#/volume] in Blood

2884

25590

1.24

14.97

6.5

5.7

e9/l

0.5

0.64

2581

22623

(3030467) Casts [#/volume] in Urine by Automated count

1447

11860

1.29

14.82

3.1

2.7

e6/l

0.4

0.3

0.43

1061

8726

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

5048

47847

1.32

14.48

10.2

9.2

ml/min/173m2

89.8

0.06

4166

39244

(42870588) Differential panel, method unspecified - Blood

1914

16292

1.25

14.23

6.5

5.8

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4003

36931

1.24

14.05

7.5

6.7

u/l

71.9

73.2

1.52

3766

34886

(3006315) Basophils [#/volume] in Blood

2883

25695

1.23

13.97

6.6

5.7

e9/l

0.0

0.47

2578

22660

(3013650) Neutrophils [#/volume] in Blood by Automated count

3250

29401

1.23

13.40

9.2

8.5

e9/l

3.9

0.18

2879

25995

(46235355) HIV 1 and 2 tests - Meaningful Use set

1842

15707

1.25

13.27

2.2

1.9

—

(3019198) Lymphocytes [#/volume] in Blood

2959

26564

1.22

12.98

6.5

5.6

e9/l

2.0

0.09

2733

23925

(3013115) Eosinophils [#/volume] in Blood

2967

26671

1.22

12.75

6.7

5.9

e9/l

0.2

0.44

2726

23941

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2171

18913

1.23

12.68

5.3

4.8

mmol/l

1.2

0.15

2005

17277

(3035350) Ketones [Presence] in Urine by Test strip

2875

25796

1.22

12.48

3.5

3.3

estimate

0.0

0.09

520

4967

(3006504) Eosinophils/100 leukocytes in Blood

2686

24006

1.21

11.93

6.5

5.7

2.8

0.02

2515

22461

(3009261) Glucose [Presence] in Urine by Test strip

2902

26137

1.21

11.89

3.6

3.3

estimate

0.0

0.03

526

5056

(3021601) Nitrite [Presence] in Urine by Test strip

2883

25960

1.21

11.81

4.8

4.5

estimate

0.0

0.47

539

5127

(3025941) Bacteria identified in Stool by Culture

483

3474

1.42

11.59

1.3

1.2

—

(3019069) Monocytes/100 leukocytes in Blood

2693

24127

1.21

11.52

6.7

6.0

8.0

7.9

0.03

2539

22767

(3022096) Basophils/100 leukocytes in Blood

2588

23173

1.20

10.94

6.6

5.8

0.7

0.29

2426

21688

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2003

17504

1.22

10.92

1.8

pmol/l

99.2

99.7

0.17

1066

9114

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

587

4423

1.36

10.67

2.3

u/l

42.1

35.4

0.45

504

3761

(3048689) Calprotectin [Mass/mass] in Stool

991

8047

1.28

10.51

2.4

2.3

ug/g

112.6

98.8

0.59

785

6272

(3002030) Lymphocytes/100 leukocytes in Blood

2775

25087

1.20

10.35

6.5

5.7

30.1

29.7

1.54

2603

23585

(3033658) Prothrombin time (PT) actual/Normal

1377

11634

1.24

10.33

4.0

3.2

96.5

98.3

2.11

1336

11272

(3018010) Neutrophils/100 leukocytes in Blood

2740

24759

1.19

10.23

6.4

5.5

56.0

56.5

1.79

2581

23346

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2368

21184

1.19

9.73

6.1

5.5

mmol/l

1.2

0.39

2073

17897

(42529406) Shigella sp [Presence] in Stool by Culture

247

1625

1.54

9.31

1.2

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

246

1618

1.54

9.29

1.2

1.1

—

(3021589) Normoblasts [#/volume] in Blood

2507

22605

1.19

9.27

8.5

8.1

e9/l

0.0

0.54

2084

18589

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

243

1606

1.53

8.99

1.2

1.1

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2623

23792

1.18

8.92

5.7

5.4

umol/l

9.4

9.6

0.90

2491

22409

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

821

6656

1.27

8.73

1.7

1.6

1.3

0.08

737

6001

(3007853) Bacteria identified in Skin by Aerobe culture

701

5582

1.29

8.60

1.7

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

175

2.64

8.59

1.5

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

497

3791

1.34

8.33

1.6

1.5

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

5263

50872

1.25

8.21

11.9

10.5

mmol/l

139.6

0.28

5142

49585

(3015736) pH of Urine

2206

19827

1.18

8.16

3.3

3.1

—

6.0

—

(3018418) pH of Serum or Plasma

1458

12673

1.20

7.91

4.4

3.5

7.4

0.22

226

2464

(3023103) Potassium [Moles/volume] in Serum or Plasma

5273

51027

1.25

7.83

12.1

10.6

mmol/l

3.9

0.20

5141

49606

(3045414) Leukocytes [Presence] in Urine

327

2360

1.41

7.75

1.9

1.8

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

5413

52554

1.27

7.73

12.4

10.7

mg/l

18.6

18.7

0.09

4251

40521

(40761511) CBC panel - Blood by Automated count

5691

55629

1.35

7.68

10.9

10.0

—

(3002256) Pathology report gross observation

830

6835

1.25

7.67

1.2

—

(3026008) Bacteria identified in Urine by Culture

1666

14688

1.18

7.65

2.8

2.6

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

2078

18679

1.17

7.51

5.0

4.2

g/l

36.7

36.6

0.27

1955

17453

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1628

14351

1.18

7.46

1.3

u/ml

1.5

0.02

500

4196

(3044889) 12 lead EKG panel

3447

32215

1.16

7.44

3.0

2.9

—

(3014051) Protein [Presence] in Urine by Test strip

178

1152

1.56

7.30

2.1

1.9

—

(3003327) Ova and parasites identified in Stool by Light microscopy

308

2226

1.40

7.26

1.6

1.7

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1923

17242

1.17

7.08

3.5

3.0

u/l

31.3

30.0

0.23

1838

16491

(3019150) Specific gravity of Urine by Refractometry

1262

10942

1.19

6.92

3.9

3.6

kg/l

1.0

0.32

169

1643

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

905

7614

1.22

6.81

2.5

mmol/l

2.4

0.28

759

6659

(3026782) Osmolality of Urine

978

8293

1.21

6.80

2.9

2.5

mosm/kgh2o

496.5

521.1

2.92

844

7041

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1359

11879

1.19

6.78

2.0

1.9

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

465

3627

1.31

6.68

1.5

1.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1078

9242

1.20

6.67

1.5

nmol/l

22.2

21.3

0.69

956

8125

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2455

22493

1.15

6.67

2.4

2.3

nmol/l

77.1

3983.2

0.50

2265

20985

(3007164) IgA [Mass/volume] in Serum or Plasma

1378

12082

1.18

6.61

1.5

1.4

g/l

2.2

2.1

0.54

831

7731

(3012095) Magnesium [Moles/volume] in Serum or Plasma

774

6427

1.23

6.60

3.2

3.0

mmol/l

0.8

0.62

719

6012

(3044640) Blood type and Crossmatch panel - Blood

1789

16030

1.16

6.53

2.2

2.0

—

(3022145) Colonoscopy Study observation

655

5350

1.25

6.49

1.4

1.3

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

584

4721

1.26

6.33

6.7

4.7

mmol/l

1.1

1.0

0.62

544

4404

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1644

14671

1.17

6.29

2.4

u/l

53.5

57.5

3.72

1541

13619

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5197

50434

1.21

6.21

5.3

5.1

mu/l

2.2

1.9

0.29

4927

47813

(3052851) Hemolysis interference index of Serum or Plasma

191

1304

1.48

6.17

4.0

2.5

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

234

2.15

6.02

3.2

2.7

41.6

46.0

0.50

(3000850) Epithelial cells [#/volume] in Urine

1053

9090

1.19

6.00

2.7

2.3

e6/l

7.7

8.5

0.65

912

7877

(3022621) pH of Urine by Test strip

414

3237

1.30

5.87

2.4

2.7

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

148

2.44

5.84

3.4

2.5

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

329

2494

1.34

5.82

1.1

u/ml

40.1

3.1

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1375

12183

1.17

5.69

1.9

2.0

u/l

115.0

141.3

2.57

1318

11542

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5617

55028

1.27

5.68

10.0

8.8

u/l

23.7

23.9

0.25

5484

53514

(3029937) Albumin [Presence] in Urine by Test strip

1519

13564

1.16

5.67

3.8

3.6

estimate

0.0

2.54

540

5076

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

442

3505

1.28

5.63

1.7

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

249

1817

1.39

5.62

1.4

u/l

28.0

25.5

0.60

206

1505

(3021879) Hepatitis B virus core Ab [Presence] in Serum

620

5118

1.24

5.58

1.5

1.4

—

(3037522) Nuclear Ab [Titer] in Serum

995

8605

1.19

5.52

1.4

titre

571.6

596.2

0.18

232

1783

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

650

5402

1.23

5.49

2.9

2.3

umol/l

5.4

6.1

0.94

557

4549

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1221

10757

1.17

5.41

1.3

u/ml

9.5

9.7

0.04

517

4608

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4660

44948

1.16

5.35

4.6

4.5

pmol/l

14.4

0.20

4391

42301

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

104

641

1.63

5.34

1.6

1.5

—

(3022217) INR in Platelet poor plasma by Coagulation assay

485

3922

1.26

5.26

14.6

14.0

inr

1.1

0.21

648

(3015171) Extractable nuclear Ab [Units/volume] in Serum

347

2691

1.31

5.25

1.3

u/ml

1.9

1.2

0.34

228

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4568

44020

1.15

5.23

4.5

4.4

mmol/mol

37.4

37.8

2.49

4301

41597

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

832

7117

1.20

5.22

3.0

ng/l

123.4

288.1

2.73

456

4011

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1492

13378

1.15

5.20

1.7

—

(3005719) IgG [Mass/volume] in Serum or Plasma

474

3838

1.25

5.09

2.9

2.6

g/l

10.3

10.5

0.44

443

3522

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

329

1.86

5.01

2.5

2.9

e6/l

789.2

852.6

0.23

153

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

126

826

1.54

5.01

6.1

5.0

iu/ml

622.4

582.1

0.04

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1265

11235

1.16

5.01

1.4

1.3

iu/ml

27.5

29.4

0.17

398

3576

(3035941) MCH [Entitic mass]

5956

58926

1.49

4.99

18.0

16.0

30.2

30.0

18.89

5903

58414

(3024731) MCV [Entitic volume]

5956

58928

1.49

4.96

18.0

16.0

90.9

90.3

18.11

5903

58418

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

257

1926

1.35

4.95

1.4

1.5

—

(3042936) Bacteria identified in Isolate by Culture

705

5968

1.21

4.95

2.0

1.8

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1349

12049

1.15

4.94

1.7

mg/l

0.9

0.11

983

9012

(3026361) Erythrocytes [#/volume] in Blood

5956

58935

1.49

4.88

18.1

16.1

e12/l

4.4

5.88

5830

57802

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4994

48506

1.16

4.87

3.8

3.7

mmol/l

5.6

0.52

4675

45484

(3010813) Leukocytes [#/volume] in Blood

5956

58943

1.48

4.78

18.1

16.1

e9/l

6.7

6.6

0.54

5832

57771

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2192

20255

1.13

4.76

3.5

3.4

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

494

4054

1.24

4.72

6.5

6.3

mmol/l

104.7

0.03

485

3981

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

140

954

1.48

4.66

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

181

1295

1.41

4.65

1.4

ug/g

324.6

304.1

0.71

116

675

(3000963) Hemoglobin [Mass/volume] in Blood

5956

58956

1.47

4.63

18.1

16.2

g/l

133.1

133.0

0.56

5908

58435

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

246

1852

1.34

4.62

2.7

1.9

g/l

0.2

1.12

232

1751

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

164

1155

1.43

4.61

1.6

—

(3051611) Lipemic interference index of Serum or Plasma

405

1.74

4.60

4.2

2.7

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

2790

26187

1.12

4.60

4.2

3.8

mmol/l

6.3

0.45

2573

23720

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

207

1521

1.37

4.55

4.6

4.1

mmol/l

24.2

0.07

193

1346

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1362

12239

1.15

4.53

1.6

mmol/l

1.4

1.3

0.21

1198

10629

(40768797) Stomach Pathology biopsy report

792

6831

1.18

4.51

1.2

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

366

2918

1.27

4.51

1.8

1.6

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

581

4882

1.21

4.42

5.4

5.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

2.69

4.41

1.0

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4971

48353

1.15

4.38

3.4

3.3

mmol/l

1.2

0.30

4692

45721

(3019309) Folate [Moles/volume] in Red Blood Cells

787

6811

1.18

4.31

1.7

nmol/l

1206.3

1189.7

0.21

641

5307

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5178

50546

1.16

4.23

3.8

3.6

mmol/l

4.9

1.05

4937

48036

(3007461) Platelets [#/volume] in Blood

5947

58888

1.42

4.20

18.1

16.1

e9/l

269.6

269.1

0.23

5831

57828

(3051651) Icteric interference index of Serum or Plasma

248

1.90

4.19

4.8

3.0

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

248

1899

1.32

4.18

1.3

u/ml

41.5

32.0

0.36

143

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

269

2085

1.30

4.16

1.4

1.3

—

(3020779) Urea [Moles/volume] in Serum or Plasma

332

2659

1.26

3.98

8.9

6.7

mmol/l

8.2

7.5

1.02

317

2556

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

5224

51078

1.16

3.95

4.1

3.9

mmol/l

2.9

0.92

4929

48212

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

695

5998

1.18

3.94

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

131

2.22

3.91

1.1

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

131

2.22

3.91

1.1

1.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

431

3562

1.23

3.90

2.4

2.3

ml/min/173m2

69.6

75.7

2.14

152

1338

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

248

1921

1.30

3.88

2.7

1.9

g/l

1.1

1.2

2.00

236

1823

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2652

24979

1.11

3.86

3.7

3.8

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

544

4608

1.20

3.82

3.1

3.4

pmol/l

4.5

0.15

475

4160

(3000991) Gas panel - Venous blood

329

2648

1.26

3.79

7.1

7.7

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

414

1.65

3.78

1.6

2.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.53

3.76

5.7

12.9

mmol/l

4.1

5.1

0.83

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

222

1.90

3.76

1.8

2.3

umol/l

153.3

167.0

0.11

117

(21494815) CD4 cells/100 lymphocytes in Specimen

408

1.65

3.73

2.4

2.1

40.9

46.6

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5144

50284

1.15

3.70

3.7

3.6

mmol/l

1.6

0.18

4871

47676

(3019832) Treponema pallidum Ab [Presence] in Serum

1163

10476

1.14

3.67

1.6

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

364

1.68

3.67

1.1

1.2

titre

405.0

202.6

0.65

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

364

1.68

3.67

1.1

1.2

titre

26.0

98.8

—

(3020961) Endomysium IgA Ab [Titer] in Serum

402

3322

1.22

3.65

1.1

titre

413.8

227.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

470

3945

1.21

3.65

1.5

1.6

—

(3023511) Choriogonadotropin [Units/volume] in Urine

327

2643

1.25

3.65

1.4

1.3

—

(3000494) Fungus identified in Specimen by Culture

648

5597

1.18

3.65

1.5

1.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

159

1166

1.37

3.62

3.1

3.2

u/ml

221.6

367.0

0.27

131

982

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

258

2029

1.28

3.62

2.7

2.1

—

(40761535) Cells panel - Urine sediment

403

3336

1.22

3.61

3.8

3.4

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1689

15583

1.12

3.56

3.2

3.1

mmol/l

2.3

2.4

1.71

1495

13990

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

369

3037

1.23

3.50

4.0

3.3

ng/l

80.9

75.3

0.55

337

2672

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

463

3899

1.20

3.49

1.5

1.6

—

(3000492) Spirometry study

604

5211

1.18

3.45

1.4

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

650

5658

1.17

3.33

2.2

2.0

29.3

29.1

0.32

633

5467

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

203

1567

1.31

3.31

2.5

2.2

165.9

168.6

0.20

194

1478

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

523

4482

1.18

3.25

2.5

2.9

u/ml

31.9

39.9

1.02

500

4341

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

184

2386

0.76

3.23

1.4

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1324

12113

1.12

3.21

2.2

2.1

mg/l

2.7

0.03

1144

10443

(3021447) Carbon dioxide [Partial pressure] in Venous blood

344

2839

1.22

3.20

4.1

3.6

kpa

5.9

5.8

0.80

337

2741

(3011288) Drugs identified in Urine by Screen method

259

2073

1.26

3.19

2.6

—

(3002032) Base excess in Venous blood by calculation

341

2815

1.22

3.17

4.1

3.6

mmol/l

2.1

1.9

0.43

286

2280

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

138

1013

1.37

3.17

3.8

2.8

mg/l

1.4

1.3

0.41

128

954

(3009508) Creatinine [Moles/volume] in Urine

1293

11824

1.12

3.15

3.4

3.1

mmol/l

7.2

0.05

1101

10166

(36660697) Celiac disease serology panel - Serum

586

5084

1.17

3.14

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

381

1.61

3.13

2.1

2.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.23

3.05

1.1

1.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

453

3858

1.19

3.04

4.3

4.0

u/l

227.2

236.9

0.79

433

3644

(4034850)

202

1578

1.29

3.04

8.5

7.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

355

2957

1.21

3.03

1.9

1.8

g/l

1.3

1.4

0.63

329

2733

(3004789) Transferrin [Mass/volume] in Serum or Plasma

701

6185

1.15

3.01

2.6

2.2

g/l

2.4

2.5

1.15

648

5739

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

908

8161

1.13

2.96

2.5

2.6

ng/l

677.5

724.3

0.23

754

6676

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3840

37094

1.10

2.95

3.0

2.8

u/l

35.5

35.0

0.16

3691

35337

(3023368) Bacteria identified in Blood by Culture

1038

9413

1.12

2.92

4.0

3.7

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

281

2297

1.23

2.90

2.4

2.0

—

(3028707) Methadone [Presence] in Urine by Screen method

169

1299

1.31

2.89

2.7

2.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

419

3562

1.19

2.89

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

102

724

1.42

2.89

2.5

1.6

iu/ml

31.3

31.5

—

(3004588) Protein electrophoresis panel - Serum or Plasma

257

2082

1.24

2.88

2.3

2.1

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2998

28669

1.09

2.85

3.0

2.9

ug/l

73.9

72.4

0.24

2856

27190

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1577

14654

1.10

2.81

2.7

ng/l

22.7

82.3

0.69

705

6824

(3001964) Herpes simplex virus Ag [Presence] in Specimen

158

1.90

2.79

1.4

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

368

3103

1.20

2.79

1.4

1.3

miu/ml

210.8

236.7

0.77

191

1602

(3022948) Iron [Moles/volume] in Serum or Plasma

770

6876

1.14

2.78

2.6

2.2

umol/l

14.4

14.2

0.35

725

6379

(4268621)

680

1.42

2.76

2.4

2.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

122

902

1.36

2.73

1.3

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

145

1101

1.32

2.72

1.4

1.5

iu/ml

12.6

15.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

206

1639

1.27

2.72

1.7

1.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4481

43667

1.10

2.70

3.8

3.7

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

461

3977

1.17

2.69

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

111

811

1.38

2.68

1.3

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

111

811

1.38

2.68

1.3

1.2

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

287

2375

1.22

2.66

1.6

1.5

—

(40768443) Skin Pathology biopsy report

254

2077

1.23

2.64

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

181

1423

1.28

2.64

1.5

1.7

titre

335.0

341.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

271

3271

0.82

2.62

1.4

1.5

—

(4198724)

297

1.62

2.61

2.7

2.6

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

212

1702

1.25

2.60

1.4

1.3

u/ml

18.4

4.7

1.08

176

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

215

1729

1.25

2.60

1.4

1.3

u/ml

19.4

8.5

0.96

299

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.60

2.57

1.0

1.8

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

133

1008

1.33

2.55

1.3

1.2

u/ml

3.2

2.9

0.11

335

(3042733) HLA Ab [Presence] in Serum

108

2.04

2.51

4.8

5.3

—

(3002385) Erythrocyte distribution width [Ratio]

4663

45578

1.10

2.50

14.9

12.9

13.5

0.49

4585

44737

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

3.81

2.46

1.0

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

211

1.71

2.42

2.2

1.9

mg/l

9.0

9.9

0.40

172

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

5.00

2.40

1.0

1.1

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

320

1.57

2.40

3.0

2.7

—

28.5

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

191

1532

1.25

2.39

1.3

u/ml

36.0

39.6

0.14

171

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

481

4205

1.16

2.39

2.3

au/ml

18.2

25.2

1.08

329

(3004616) Nuclear Ab [Presence] in Serum

726

1.37

2.38

1.4

1.3

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

339

2883

1.19

2.38

5.4

6.2

mmol/l

1.1

1.2

2.15

323

2785

(3016879) Cocaine [Presence] in Urine

324

2748

1.19

2.35

2.4

1.9

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

216

1762

1.23

2.34

1.6

u/ml

4.7

7.7

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

568

5035

1.14

2.32

2.1

u/l

3814.2

5995.0

0.82

206

2091

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

173

1378

1.26

2.31

2.2

1.8

g/l

1.4

0.03

151

1189

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

428

1.48

2.31

1.3

—

(3022689) Creatine [Moles/volume] in Urine

119

1.94

2.30

2.0

1.5

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

623

5563

1.13

2.28

2.8

2.3

23.5

0.02

562

4797

(3024354) Oxygen [Partial pressure] in Venous blood

275

2307

1.20

2.26

3.1

kpa

4.5

4.6

0.75

265

2221

(3024891) Influenza virus A+B Ag [Presence] in Specimen

189

1527

1.25

2.24

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

5.56

2.21

2.4

4.2

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

172

1.75

2.20

1.8

1.6

au/ml

139.2

141.9

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

215

1767

1.22

2.19

1.6

iu/ml

0.1

9.6

0.51

351

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.50

2.18

6.0

5.9

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

426

1.46

2.17

1.3

1.2

u/ml

69.4

63.2

—

(3019225) pH of Specimen

457

4014

1.15

2.15

3.3

3.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

146

1151

1.28

2.15

1.2

—

(1761868) Lipid panel - Serum or Plasma

2017

21222

0.93

2.14

2.2

2.3

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

672

1.36

2.13

1.2

1.1

94.7

93.8

0.11

635

(3028300) Cannabinoids [Presence] in Urine

352

3035

1.17

2.13

2.4

1.9

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

127

985

1.30

2.12

1.3

1.2

u/ml

2.7

4.0

1.75

402

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1589

14949

1.09

2.10

1.7

1.6

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

175

1.72

2.09

8.3

4.8

u/ml

48.2

280.2

—

(40768446) Kidney Pathology biopsy report

138

1.81

2.08

2.0

1.5

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1208

11235

1.09

2.08

2.5

2.1

umol/l

1736.6

2902.4

0.97

1071

10003

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

268

1.57

2.08

1.2

u/l

25.3

17.7

0.26

233

(3008898) HLA-B27 [Presence]

332

2856

1.17

2.07

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

107

814

1.32

2.07

3.7

3.3

mg/l

34.9

42.1

0.54

663

(3036481) Cortisol [Moles/volume] in Serum or Plasma

582

5212

1.13

2.05

2.1

nmol/l

385.4

373.9

0.66

544

4795

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

107

815

1.32

2.05

3.7

3.3

mg/l

30.9

41.1

0.59

662

(3028433) Virus identified in Specimen by Culture

161

1.74

2.05

1.2

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

348

3009

1.17

2.04

2.4

1.9

—

(3045424) Erythrocytes [Presence] in Urine

111

853

1.31

2.01

1.7

1.5

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

140

1.79

2.00

1.6

1.9

ug/l

1.5

4.1

0.68

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

245

2901

0.84

2.00

1.6

1.8

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

155

1.75

1.99

1.1

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

155

1.75

1.99

1.1

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

125

977

1.29

1.99

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

121

942

1.29

1.99

2.1

2.0

g/l

0.0

0.93

111

872

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

410

1.44

1.98

1.3

1.2

u/ml

23.8

6.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

621

1.36

1.98

1.1

—

(3027008) Opiates [Presence] in Urine

349

3027

1.16

1.97

2.4

1.8

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

427

1.43

1.97

1.3

1.2

u/ml

58.2

49.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

167

1354

1.24

1.96

1.4

1.3

u/ml

1.2

3.7

1.35

(3030981) Hyaline casts [#/volume] in Urine by Automated count

242

2037

1.20

1.96

3.0

2.4

e6/l

0.3

0.2

0.04

227

1944

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

439

3875

1.14

1.95

1.2

1.3

au/ml

34.2

38.0

0.15

171

(3000034) Microalbumin [Mass/volume] in Urine

338

1.48

1.93

3.0

2.8

mg/l

114.1

50.2

0.38

234

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

195

1.64

1.92

1.1

1.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

489

1.40

1.90

1.7

2.0

mg/l

26.6

27.4

0.05

134

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

200

1662

1.21

1.87

2.3

1.9

96.4

95.6

0.21

183

1513

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

131

1040

1.27

1.86

1.3

1.2

—

(3037121) Protein [Mass/volume] in Urine

165

1345

1.23

1.86

2.8

2.9

g/l

0.3

0.07

493

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

491

1.39

1.86

1.1

1.2

u/l

57.1

57.3

0.01

326

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

136

1085

1.26

1.86

1.3

1.2

u/ml

327.5

268.5

1.42

717

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

424

3750

1.14

1.84

2.6

2.2

g/l

0.2

0.33

405

3547

(44816559) Phosphatidylethanol [Mass/volume] in Blood

129

1026

1.26

1.82

1.2

1.3

—

(3023410) Appearance of Cerebral spinal fluid

597

1.34

1.80

1.6

1.4

—

(3027944) Amphetamines [Presence] in Urine

343

2999

1.15

1.77

2.4

1.8

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

200

1.60

1.76

1.1

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

617

1.33

1.76

1.3

1.6

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

272

1.51

1.75

1.2

u/l

81.5

75.7

0.19

241

(3022493) Free Hemoglobin [Mass/volume] in Plasma

139

1.73

1.75

1.5

5.2

mg/l

64.8

1206.3

0.49

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

322

1.46

1.73

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.92

1.72

1.0

1.7

—

(3034426) Prothrombin time (PT)

210

1.57

1.70

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

195

1.59

1.68

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.38

1.67

1.1

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

617

6763

0.90

1.66

1.4

1.5

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

367

0.60

1.64

7.8

12.0

nmol/l

786.7

856.9

0.27

354

(40760888) Immunoglobulin light chains.free panel - Serum

607

1.32

1.64

4.1

3.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

238

2045

1.17

1.58

1.2

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

100

787

1.28

1.58

3.5

3.2

ratio

1.0

1.4

—

(3011648) Oxygen content in Venous blood

263

1.49

1.57

2.3

10.2

11.0

0.62

263

(3023323) Follitropin [Units/volume] in Serum or Plasma

665

6099

1.10

1.57

1.3

iu/l

27.4

27.8

0.11

575

5352

(3017354) Segmented neutrophils/100 leukocytes in Blood

346

1.42

1.57

2.2

2.5

55.0

56.2

0.15

219

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

419

3750

1.13

1.55

3.6

ug/l

25.7

25.2

0.01

315

2745

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

573

5226

1.11

1.52

3.7

3.6

32.2

32.8

0.80

425

3818

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

315

1.43

1.52

2.2

2.6

—

(3027945) Reticulocytes/100 erythrocytes in Blood

401

3588

1.13

1.50

2.8

2.4

1.7

0.04

359

3197

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

382

0.63

1.50

8.5

17.0

nmol/l

1320.4

4031.9

0.55

367

(3052592) Norovirus Ag [Presence] in Stool

2.07

1.49

1.2

1.3

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

150

1245

1.21

1.48

1.5

1.4

e6/l

26174.8

1429.2

0.48

117

1018

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

150

1245

1.21

1.48

1.5

1.3

e6/l

60.1

24.0

0.71

112

962

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.22

1.46

1.0

1.1

umol/24h

1.4

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

619

1.30

1.46

4.0

5.5

umol/l

379.3

374.7

0.09

528

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

3.13

1.44

1.2

1.0

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

106

853

1.25

1.42

2.1

2.0

g/l

0.0

0.00

794

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

129

1061

1.22

1.41

2.5

2.1

ug/l

452.1

521.9

0.08

113

944

(3032080) INR in Blood by Coagulation assay

1546

14732

1.07

1.40

5.9

5.6

inr

1.1

0.32

473

4804

(3024980) IgG subclass 4 [Mass/volume] in Serum

111

900

1.24

1.39

1.5

g/l

0.6

0.26

670

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

134

1109

1.21

1.39

1.4

1.3

—

(3021788) Differential panel - Synovial fluid

704

1.27

1.38

1.6

—

(3000330) Specific gravity of Urine by Test strip

237

2061

1.16

1.38

2.9

—

(4062490)

607

1.29

1.38

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

274

2409

1.14

1.37

1.6

1.7

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2.20

1.36

1.3

1.1

—

11.5

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

126

1039

1.22

1.36

2.4

2.1

g/l

0.4

0.6

0.32

113

918

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

257

1.44

1.33

1.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

106

861

1.24

1.32

2.1

2.0

g/l

0.0

0.50

796

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

166

1409

1.18

1.32

1.3

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

462

1.32

1.3

titre

—

(21494890) Protein electrophoresis panel - 24 hour Urine

266

1.43

1.31

2.6

1.9

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1567

14969

1.06

1.31

2.9

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

176

1.54

1.31

1.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

112

917

1.23

1.30

2.3

2.6

—

(3023183) Ammonium ion [Moles/volume] in Plasma

631

1.27

1.29

2.5

2.8

umol/l

33.1

33.3

0.02

552

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

647

0.74

1.29

1.1

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

106

1.70

1.29

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

114

938

1.22

1.27

2.1

2.0

g/l

38.7

38.8

0.05

103

832

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

518

1.30

1.26

1.1

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

518

1.30

1.26

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

518

1.30

1.26

1.1

1.2

—

(21494755) Public health laboratory ask at order entry panel

712

7645

0.92

1.26

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

205

1779

1.16

1.25

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

510

1.30

1.25

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

510

1.30

1.25

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

146

1.58

1.25

1.2

1.1

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

172

1473

1.17

1.25

2.7

2.4

g/l

3.6

0.07

166

1381

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

160

1362

1.18

1.25

2.6

2.1

mg/l

9.5

10.4

1.03

154

1280

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

211

1.47

1.24

1.2

1.3

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

511

1.29

1.24

1.2

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

321

1.37

1.22

1.1

u/ml

4.9

7.7

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

125

1043

1.20

1.22

1.3

1.4

—

(3012516) Albumin [Mass/volume] in Urine

1054

9967

1.07

1.21

3.7

3.2

mg/l

385.2

499.4

0.33

628

5891

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

229

1.44

1.21

1.1

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

325

0.64

1.21

1.6

1.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1098

10402

1.07

1.20

4.2

3.9

mg/mmol

11.0

9.2

0.49

653

6311

(3028192) IgG subclass 2 [Mass/volume] in Serum

612

1.26

1.19

1.3

1.4

g/l

2.7

3.0

1.03

420

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

123

1029

1.20

1.18

1.4

1.3

u/ml

114.2

110.2

0.19

232

(3024139) IgG subclass 3 [Mass/volume] in Serum

613

1.26

1.18

1.3

1.4

g/l

0.4

0.11

419

(3027135) IgG subclass 1 [Mass/volume] in Serum

613

1.26

1.18

1.3

1.4

g/l

7.7

6.5

1.51

420

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

489

1.29

1.17

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

811

1.22

1.17

2.4

2.6

—

(3036489) Thrombin time

221

1941

1.14

1.16

2.1

1.8

20.7

0.08

190

1616

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

102

1.67

1.16

1.1

1.2

pmol/l

374.4

312.0

0.26

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

464

1.30

1.15

1.3

1.2

—

(40768441) Liver Pathology biopsy report

368

1.33

1.15

1.6

1.3

—

(4212803)

2.50

1.15

1.0

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.73

1.15

1.1

umol/24h

0.6

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

134

1.57

1.14

1.9

2.0

ug/min

2.6

106.9

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

136

1153

1.18

1.14

2.6

2.1

g/l

3.0

0.20

112

906

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

431

1.30

1.12

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

159

1.51

1.11

1.1

1.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

330

0.67

1.11

1.1

1.3

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.96

1.11

1.3

2.3

—

(4306422)

118

991

1.19

1.10

1.2

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

257

0.62

1.10

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

380

1.32

1.10

2.7

2.6

e9/l

0.2

0.12

316

(3017732) Neutrophils [#/volume] in Blood

432

3960

1.10

2.1

2.3

e9/l

4.0

4.1

0.39

366

3309

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

113

946

1.20

1.09

1.2

1.1

122.1

119.0

0.54

104

864

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

469

1.28

1.08

1.3

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

165

0.54

1.07

1.1

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

347

1.33

1.07

1.0

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

169

1.48

1.07

1.0

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

577

1.25

1.06

1.1

1.2

mg/l

33.6

35.7

0.21

486

(3010144) Erythrocytes [#/volume] in Synovial fluid

330

1.34

1.06

1.4

1.5

e6/l

8706.5

60640.9

1.14

228

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

287

1.36

1.06

4.2

4.0

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.27

1.03

1.2

1.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

324

0.68

1.03

1.9

2.0

—

(4027681)

455

1.28

1.03

1.2

—

(4211845)

272

1.36

1.02

2.6

2.7

—

(4010399)

355

3237

1.10

1.02

1.4

—

(3024471) HLA-A [Type]

122

1.56

1.02

1.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

265

1.36

0.99

1.6

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

387

1.29

0.99

2.7

2.5

e6/l

588.4

509.6

0.61

316

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

258

2318

1.12

0.99

2.0

ug/l

4.9

5.3

0.21

228

2026

(3038515) Glucose [Moles/volume] in Venous blood

584

0.77

0.98

2.2

2.5

mmol/l

7.2

0.02

569

(3023520) Reticulocytes [#/volume] in Blood

276

2490

1.11

0.98

2.5

e9/l

68.3

72.3

1.19

203

1818

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

185

1629

1.14

0.98

6.8

8.3

mmol/l

24.4

24.2

0.36

173

1536

(3000060) B lymphocytes [#/volume] in Blood

181

1.44

0.98

2.2

e6/l

192.7

181.8

0.07

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

353

1.31

0.97

1.0

—

(3006462) Nitrate [Presence] in Urine

249

1.37

0.97

2.8

2.7

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

108

1.58

0.96

1.0

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

460

1.26

0.96

1.7

1.5

—

(3011412) CD3 cells [#/volume] in Blood

515

1.25

0.94

2.8

2.4

e9/l

1.2

1.3

0.22

300

(3025018) Bordetella pertussis Ab [Titer] in Serum

417

1.27

0.94

1.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

317

3473

0.91

0.94

4.0

3.1

mmol/l

1.2

2.04

280

3040

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

391

1.28

0.93

2.7

2.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

193

1712

1.13

0.93

2.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

644

1.21

0.91

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

244

0.65

0.91

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

287

1.33

0.91

1.5

1.6

u/l

8.1

4.1

0.51

136

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

613

5757

1.07

0.90

1.2

iu/ml

144.1

151.2

0.18

218

2370

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

627

1.21

0.90

1.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

113

970

1.17

0.87

1.6

1.4

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

161

1419

1.14

0.87

3.2

3.0

0.6

0.7

0.37

155

1355

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

449

1.25

0.87

1.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

136

1.47

0.86

1.4

2.3

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

161

1.43

0.86

2.5

2.0

umol/l

16.7

16.1

0.11

161

(3024932) HLA-DR beta [Type]

120

1.50

0.85

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

170

1.41

0.85

1.3

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

1.63

0.84

1.1

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

162

1.42

0.84

1.0

1.1

mg/g

4.8

5.0

0.11

154

(3008757) Leukocyte morphology finding [Identifier] in Blood

362

1.27

0.83

2.3

3.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

551

1.22

0.83

1.0

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

235

2126

1.11

0.83

2.4

2.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

138

0.58

0.83

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

112

0.54

0.83

1.5

1.6

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

160

1416

1.13

0.82

1.4

1.2

mg/l

478.3

466.9

0.07

152

1361

(3006922) Hepatitis E virus Ab [Presence] in Serum

390

1.26

0.82

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

1.88

0.81

1.0

1.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

346

1.27

0.81

1.4

1.6

promille

1.2

0.19

258

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

232

2102

1.11

0.80

1.3

1.5

pmol/l

71.4

111.2

2.44

227

2056

(3020630) Protein [Mass/volume] in Serum or Plasma

286

2619

1.10

0.80

2.4

2.5

g/l

66.3

67.3

1.37

259

2416

(3002523) Influenza virus A Ag [Presence] in Specimen

137

1203

1.14

0.80

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

137

1203

1.14

0.80

1.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

127

1110

1.15

0.79

2.7

2.1

g/l

9.6

10.2

0.83

112

957

(3007456) Orange IgE Ab [Units/volume] in Serum

0.00

0.79

0.0

1.0

—

0.1

—

(3016018) Differential panel - Cerebral spinal fluid

619

1.20

0.79

1.4

1.3

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

0.00

0.79

0.0

1.0

—

0.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

321

1.28

0.79

3.1

3.2

nmol/l

0.8

0.20

242

(4015189)

1.62

0.78

1.8

2.5

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

137

1206

1.14

0.78

2.6

2.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

137

1206

1.14

0.78

2.6

2.1

g/l

3.4

3.7

2.39

107

872

(40761539) Cells [Type] in Urine sediment by Light microscopy

0.52

0.78

1.0

1.1

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.77

0.0

7.0

—

(3008037) Lactate [Moles/volume] in Venous blood

628

0.81

0.77

2.1

2.4

mmol/l

1.4

0.05

611

(44790048)

448

1.23

0.76

1.4

—

(44790047)

448

1.23

0.76

1.4

—

(44806118)

448

1.23

0.76

1.4

—

(44790049)

448

1.23

0.76

1.4

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

101

871

1.16

0.76

1.4

1.3

u/ml

54.7

57.6

—

(3004451) EKG impression Narrative

115

1.48

0.76

1.3

1.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

137

1208

1.14

0.76

2.6

2.1

g/l

7.2

7.3

0.38

112

927

(3004809) Band form neutrophils/100 leukocytes in Blood

558

1.20

0.75

2.1

2.6

1.6

1.4

0.17

440

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

505

0.79

0.75

1.2

u/ml

0.1

1.1

1.51

199

(1761482) Bacteria [#/volume] in Urine by Culture

844

0.84

0.75

3.9

3.7

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

559

1.20

0.74

1.0

1.1

mg/l

194.2

211.3

0.82

495

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.08

0.74

1.0

1.8

—

(3022313) Gas panel - Capillary blood

153

1362

1.13

0.74

3.2

2.8

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

126

1108

1.14

0.74

1.1

au/ml

6.7

10.9

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

387

1.24

0.74

1.3

1.4

umol/l

12.5

9.8

1.12

370

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

469

1.22

0.73

1.3

1.4

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

838

1.16

0.73

1.0

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

281

1.28

0.72

1.5

1.7

umol/l

2.0

1.9

0.45

261

(40761536) Microorganisms panel - Urine sediment

436

4649

0.93

0.72

3.4

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

110

0.55

0.71

1.0

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

217

1975

1.10

0.71

1.4

—

(3020491) Glucose [Moles/volume] in Blood

398

1.23

0.71

1.4

1.6

mmol/l

5.8

6.0

0.19

314

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

201

1823

1.11

0.71

2.2

2.0

iu/l

3.8

4.4

0.50

753

(3025159) Blasts/100 leukocytes in Blood

388

3625

1.08

0.70

4.1

0.0

0.3

0.88

694

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

101

1.49

0.70

3.5

3.9

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

101

1.49

0.70

1.1

1.2

u/ml

0.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

101

1.49

0.70

3.5

3.9

—

(3010421) pH of Blood

965

0.86

0.69

4.8

2.9

7.4

1.48

798

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

454

1.21

0.69

1.0

1.1

iu/ml

5.0

8.1

1.02

123

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

161

1.37

0.68

3.6

3.0

umol/l

30.3

27.8

0.68

117

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

419

1.22

0.68

2.5

2.1

9.5

12.9

2.25

215

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

714

1.16

0.67

1.2

nmol/l

0.5

2.2

0.54

692

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.63

0.66

1.0

mmol/l

9.3

8.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

475

1.20

0.66

1.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

366

1.23

0.66

1.5

1.4

—

(3047181) Lactate [Moles/volume] in Blood

100

1141

0.87

0.66

6.3

5.1

mmol/l

1.1

1.2

1.03

999

(3021440) Promyelocytes/100 leukocytes in Blood

402

3773

1.07

0.65

4.0

4.1

0.1

0.2

0.49

811

(3000475) Leukocytes [#/volume] in Synovial fluid

103

903

1.14

0.65

1.8

1.7

e6/l

7554.7

8256.8

0.17

659

(3013293) Extractable nuclear Ab [Presence] in Serum

120

1.42

0.64

1.7

1.6

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

767

8007

0.95

0.64

2.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

260

1.27

0.63

1.1

1.0

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

607

1.17

0.63

1.6

1.4

pmol/l

335.9

388.3

0.39

479

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

728

1.16

0.63

1.3

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1337

12968

1.04

0.62

4.1

4.0

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

104

1.44

0.62

1.1

1.3

nmol/l

175.3

108.7

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

235

2166

1.09

0.62

2.4

2.1

u/l

40.4

39.1

0.50

224

2011

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

333

1.23

0.62

1.0

1.1

nmol/l

0.3

4.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

861

1.14

0.61

1.0

1.1

—

(1616796) Gas panel - Central venous blood

782

0.86

0.61

4.2

2.7

—

(3003396) Base excess in Arterial blood by calculation

379

3561

1.07

0.61

6.2

6.6

mmol/l

1.1

0.9

0.53

291

2721

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

126

1126

1.12

0.61

1.8

1.9

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

140

1259

1.11

0.61

1.4

1.2

mmol/l

3.5

3.6

1.08

133

1187

(3016502) Oxygen saturation in Arterial blood

327

3058

1.07

0.60

6.7

7.0

96.4

96.1

0.30

312

2939

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

138

0.65

0.60

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.60

0.0

5.1

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

0.00

0.60

0.0

1.5

—

24.4

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.57

0.60

2.3

2.1

u/field

0.8

0.9

—

(3022670) pH of Venous cord blood

0.00

0.60

0.0

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

148

1337

1.11

0.60

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

472

1.19

0.59

1.7

52.6

49.7

0.21

282

(3021387) Prolactin [Units/volume] in Serum or Plasma

374

3517

1.07

0.59

1.4

1.6

mu/l

290.2

313.2

0.75

339

3117

(3006598) pH of Arterial cord blood

0.00

0.59

0.0

1.2

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

0.00

0.59

0.0

1.0

—

0.1

—

(3004959) Base excess in Arterial cord blood by calculation

0.00

0.59

0.0

1.1

—

0.5

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.53

0.59

1.1

1.0

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

175

1.32

0.58

1.7

2.3

nmol/l

166.6

160.5

0.11

152

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

990

0.88

0.58

1.6

mmol/l

7.3

7.6

0.83

603

(3012501) Base excess in Blood by calculation

809

0.86

0.57

5.2

2.9

mmol/l

2.0

2.4

0.62

516

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

926

0.87

0.57

1.3

1.5

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

420

0.81

0.57

6.6

6.5

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

202

1858

1.09

0.57

3.1

2.8

mmol/l

1.7

1.5

0.29

142

1353

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

158

1.33

0.57

3.0

3.3

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.67

0.56

1.0

1.1

—

(3017181) Myelocytes/100 leukocytes in Blood

415

3924

1.06

0.56

4.0

0.7

0.9

0.36

870

(3017569) Oxygen content in Arterial blood

115

1.39

0.56

1.3

2.3

—

(3024928) Oxygen saturation in Venous blood

672

1.15

0.55

3.4

3.8

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.58

0.54

1.7

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

806

1.13

0.53

3.4

3.8

u/ml

0.3

0.4

0.76

458

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

1088

0.89

0.53

2.9

3.4

58.9

57.3

1.03

1088

(3011985) Renin [Units/volume] in Plasma

656

1.15

0.53

2.2

1.6

mu/l

88.9

52.3

0.55

603

(40768795) Lymph node Pathology biopsy report

469

0.83

0.52

1.1

1.2

—

(3028717) Thiamine [Mass/volume] in Blood

1.52

0.52

1.1

1.2

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

376

3556

1.06

0.52

6.3

6.5

kpa

5.1

5.0

0.44

358

3408

(3027801) Oxygen [Partial pressure] in Arterial blood

376

3556

1.06

0.52

6.4

6.5

kpa

13.6

13.4

0.24

356

3402

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

232

1.25

0.52

1.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

134

1218

1.10

0.51

3.2

2.8

mmol/l

24.8

0.05

127

1133

(3003129) Base excess in Capillary blood by calculation

1.39

0.50

1.4

2.0

mmol/l

1.2

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

584

1.15

0.50

1.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

153

1.31

0.50

1.2

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

288

1.22

0.50

1.1

—

(3020891) Body temperature

136

1239

1.10

0.50

5.4

4.2

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

325

1.20

0.49

1.5

70.3

71.3

0.13

311

(3040151) Glucose [Moles/volume] in Capillary blood

389

0.82

0.49

8.9

4.4

mmol/l

5.8

7.4

2.47

328

(3027231) Wheat IgE Ab [Units/volume] in Serum

145

1.31

0.48

1.0

—

0.7

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

586

1.14

0.48

1.4

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

784

1.12

0.48

1.1

1.3

—

100.0

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

251

2351

1.07

0.48

2.2

2.6

ng/l

174.7

122.0

0.90

220

2100

(3018572) Chloride [Moles/volume] in Blood

742

0.87

0.48

8.1

6.4

mmol/l

105.7

105.5

0.18

664

(3005988) Vibrio sp identified in Specimen by Organism specific culture

587

1.14

0.47

1.4

—

(3039000) Anion gap in Blood

741

0.88

0.47

8.1

6.4

mmol/l

10.8

11.0

0.19

663

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

210

1956

1.08

0.47

3.2

2.9

kpa

5.1

0.97

197

1828

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

870

8424

1.04

0.47

1.5

1.4

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

318

1.20

0.47

1.5

mu/l

321.4

454.1

1.61

304

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

730

1.12

0.46

1.2

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

439

1.16

0.46

1.0

1.1

—

(4094501)

116

1054

1.10

0.46

1.1

—

(3037756) Immunofixation for Serum or Plasma

533

1.15

0.45

2.1

1.6

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

0.61

0.45

1.0

u/ml

0.0

0.5

—

(3035637) Corticotropin [Mass/volume] in Plasma

646

1.13

0.45

1.5

1.6

—

(3049717) Cytology report of Urine Cyto stain

807

1.12

0.45

1.8

2.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

129

1.32

0.45

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

665

1.13

0.45

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

506

1.15

0.44

1.7

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

253

0.79

0.44

1.1

98.3

94.9

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

469

1.15

0.44

1.2

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

312

1.19

0.43

1.4

1.6

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

593

1.13

0.42

1.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

649

0.88

0.42

3.4

u/ml

192.8

634.5

0.52

590

(3013512) EKG study

1154

11256

1.03

0.42

3.1

2.9

—

(3047189) Immunofixation for 24 hour Urine

122

1.31

0.42

2.4

1.6

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.40

0.42

1.1

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

306

2902

1.06

0.42

7.2

7.3

g/l

117.8

120.8

2.25

298

2795

(3002179) Metamyelocytes/100 leukocytes in Blood

378

3606

1.05

0.42

3.8

0.8

0.6

0.13

650

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

722

0.89

0.41

4.7

4.3

u/ml

42.5

88.4

0.80

245

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

176

1.25

0.41

1.0

ng/l

264.6

338.1

1.16

132

(3010503) CD19 cells [#/volume] in Blood

295

1.19

0.41

3.0

2.7

e9/l

0.3

0.04

289

(3021901) Oxygen saturation in Capillary blood

538

1.14

0.41

2.5

2.4

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.41

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.41

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.41

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.41

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.41

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.41

0.0

2.0

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.40

0.0

1.1

—

36.8

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

597

1.12

0.39

1.4

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.39

0.0

1.2

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.39

0.0

1.2

—

69.9

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.39

0.0

10.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

655

1.12

0.38

1.2

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

167

1559

1.07

0.38

2.0

1.9

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

608

1.12

0.38

1.4

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.39

0.38

1.0

1.1

u/l

10.6

15.3

—

(3007916) DNA double strand Ab [Titer] in Serum

1.34

0.38

1.0

1.3

—

263.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

714

1.11

0.37

2.7

2.5

ug/min

81.9

0.00

443

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

179

1.23

0.37

1.0

ng/l

579.8

787.6

1.78

131

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.35

0.37

5.6

1.5

—

(3044009) aPTT.lupus sensitive (LA screen)

1.30

0.37

1.1

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

116

1.29

0.37

1.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.29

0.36

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

377

3932

0.96

0.36

1.4

1.5

—

(3044941) Cell count panel - Synovial fluid

611

1.11

0.36

1.4

—

(3018133) Calcium [Moles/volume] in Urine

1.27

0.36

2.0

1.7

mmol/l

2.6

3.1

—

(3044290) Cell count panel - Cerebral spinal fluid

128

1187

1.08

0.36

1.5

1.3

—

(3009343) pH of Capillary blood

205

1934

1.06

0.35

3.2

2.8

7.4

0.35

268

(3029396) Erythrocyte agglutination [Presence] in Blood

342

0.85

0.35

3.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

123

0.73

0.35

1.2

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

123

0.73

0.35

1.2

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

123

0.73

0.35

1.2

1.0

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

357

1.15

0.35

1.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

126

0.71

0.35

1.1

—

(3043409) Potassium [Moles/volume] in Arterial blood

900

1.09

0.34

4.5

3.9

mmol/l

3.7

3.8

0.18

849

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

1.36

0.34

1.2

1.4

19.7

19.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

901

1.09

0.34

1.4

1.5

—

(3006653) Thiamine [Moles/volume] in Blood

246

1.18

0.34

1.3

1.6

nmol/l

127.3

129.2

0.10

246

(3038177) Helicobacter pylori Ab [Presence] in Serum

125

1162

1.08

0.33

1.2

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

133

0.75

0.33

1.1

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

133

0.75

0.33

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

110

1019

1.08

0.32

1.2

—

(21494434) Karyotype in Bone marrow

238

1.18

0.32

1.0

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.28

0.32

1.5

1.6

—

(3020874) Milk IgE Ab [Units/volume] in Serum

529

0.89

0.32

1.0

u/ml

0.2

1.5

0.99

143

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

493

1.12

0.31

1.3

1.4

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

239

1.17

0.31

2.5

2.9

mg/l

7.6

7.7

0.04

179

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.35

0.31

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

202

1.19

0.31

1.4

2.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

112

1203

0.93

0.31

1.0

1.1

u/ml

0.8

4.7

4.54

442

(3009542) Hematocrit [Volume Fraction] of Blood

5052

50303

1.03

0.31

13.2

11.5

39.6

39.4

0.97

4158

40794

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

164

0.79

0.30

1.2

1.1

108.8

109.2

0.02

155

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

409

1.13

0.30

1.0

1.1

u/l

0.9

1.1

3.21

169

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

888

1.08

0.30

1.4

1.5

—

(3005322) IgE [Units/volume] in Serum or Plasma

451

4362

1.04

0.30

1.3

u/ml

134.0

180.5

0.87

414

4041

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

1.30

0.30

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

217

2065

1.05

0.30

1.2

u/l

14.6

12.0

1.54

187

1710

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

231

1.17

0.29

1.3

1.2

—

(4281824)

703

0.91

0.29

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

553

1.10

0.29

1.2

1.4

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

118

1262

0.93

0.29

5.7

4.7

0.8

0.9

1.97

112

1177

(3042631) Mycobacterium sp identified in Specimen

388

0.88

0.29

2.8

2.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

468

1.11

0.29

1.5

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

173

0.81

0.28

1.9

1.7

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.29

0.28

1.5

1.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

140

1.21

0.27

2.1

1.6

ug/l

7.1

8.3

1.60

140

(40767503) Oxygen content in Capillary blood by calculation

720

0.92

0.27

2.1

16.6

16.7

0.02

345

(3047352) Trisomy 18 risk [Likelihood] in Fetus

291

3025

0.96

0.27

1.5

1.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

227

2373

0.95

0.27

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

172

0.81

0.27

1.9

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

172

0.81

0.27

1.9

1.7

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

252

1.15

0.27

1.6

1.5

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

159

1.20

0.26

2.5

2.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.19

0.26

1.4

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

503

5171

0.97

0.26

1.7

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

770

1.08

0.26

3.0

2.8

mmol/l

24.6

24.5

0.05

676

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

0.68

0.26

1.2

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

358

3701

0.97

0.26

1.4

—

(4146454)

310

1.13

0.25

2.7

2.9

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

118

1110

1.06

0.25

1.4

1.6

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

169

1.18

0.25

1.0

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

244

1.15

0.25

1.0

1.2

u/l

26.6

18.0

0.37

198

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

244

1.15

0.25

2.3

1.8

118.3

146.8

1.73

222

(3019174) dRVVT (LA screen)

1.25

0.25

1.1

1.2

—

(3022806) Fractional oxyhemoglobin in Capillary blood

467

0.90

0.25

1.5

1.6

90.5

90.6

0.05

461

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

138

0.80

0.25

1.5

3.6

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

358

3699

0.97

0.25

1.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

627

1.09

0.25

1.1

—

(3045142) Bone marrow Pathology biopsy report

349

1.12

0.25

1.3

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

120

1272

0.94

0.24

5.4

4.6

1.7

0.00

111

1186

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

788

0.93

0.24

1.1

iu/ml

94.8

13164.0

0.63

204

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

107

1005

1.07

0.24

1.1

—

(3002619) Bacteria identified in Specimen by Culture

105

1.24

0.24

1.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

245

1.14

0.24

1.2

1.4

u/ml

11.8

19.7

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

264

1.14

0.24

1.1

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

217

1.15

0.24

1.4

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

436

1.10

0.24

1.2

1.4

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

436

1.10

0.24

1.3

1.5

mmol/l

5.3

0.15

415

(3023430) Cat dander IgE Ab [Units/volume] in Serum

106

1126

0.94

0.23

1.1

u/ml

1.3

3.7

4.10

445

(3003181) Sodium [Moles/volume] in Urine

552

1.09

0.23

1.6

1.4

mmol/l

55.8

64.9

1.29

430

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

246

1.14

0.23

1.0

1.2

u/l

78.7

77.1

0.06

204

(3005033) Fetal Nuchal fold Thickness US

291

3011

0.96

0.23

1.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

134

1.19

0.22

1.4

—

(3024263) Appearance of Synovial fluid

200

0.85

0.22

2.6

2.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.25

0.22

2.0

1.5

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

181

1.16

0.22

1.0

ng/l

32.1

46.0

1.43

135

(3044007) Cell count panel - Peritoneal fluid

0.74

0.22

3.3

2.0

—

(3033799) Differential panel - Peritoneal fluid

0.74

0.22

1.6

2.0

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

448

1.09

0.22

1.1

ratio

1.1

1.0

0.49

166

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

357

3676

0.97

0.22

1.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

622

1.08

0.22

1.5

1.6

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

793

0.93

0.22

3.5

2.4

nmol/l

0.8

0.06

669

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

191

1.15

0.21

1.2

—

(3013637) Mi-2 Ab [Presence] in Serum

124

0.81

0.21

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

124

0.81

0.21

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

124

0.81

0.21

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

124

0.81

0.21

1.0

1.1

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.21

0.0

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(40768806) Pleura Pathology biopsy report

220

0.86

0.21

1.5

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

0.21

0.0

1.7

—

(3021661) Pineapple IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.1

—

(3046861) Legionella sp Ag [Presence] in Urine

0.00

0.21

0.0

1.0

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

449

4603

0.97

0.21

1.2

1.4

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

643

1.07

0.21

1.3

1.4

mmol/l

8.3

11.4

2.25

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

15.3

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.21

0.0

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

174

1813

0.96

0.20

1.6

1.5

nmol/l

0.4

0.5

2.54

141

1439

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

154

1609

0.96

0.20

1.2

1.1

u/ml

1.9

1.2

0.41

571

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.20

0.0

2.1

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

5.9

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

155

0.84

0.20

1.2

1.1

—

(3003338) MCHC [Mass/volume]

4717

47002

1.02

0.20

15.7

13.5

g/l

331.9

331.6

1.94

4688

46689

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

359

3687

0.97

0.19

1.4

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

174

1.15

0.19

1.6

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

396

0.91

0.19

1.2

1.3

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

212

1.13

0.19

1.2

1.1

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

1.18

0.19

1.0

1.1

—

3.5

—

(40765096) Chromosome analysis panel by Banding

1.22

0.19

1.0

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

414

1.09

0.19

1.2

—

(3017704) Immunofixation for Urine

137

1.17

0.18

3.3

1.5

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

109

1.19

0.18

1.2

1.3

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

206

0.87

0.18

1.6

1.5

4.4

4.9

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.19

0.18

1.7

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.19

0.18

1.0

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

153

0.85

0.18

4.7

2.8

ng/l

198.1

95.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

151

1451

1.04

0.17

1.3

titre

189.2

142.8

0.17

136

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

177

1835

0.96

0.17

1.3

ug/l

2.8

3.5

1.29

158

1666

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

216

0.88

0.17

1.6

—

(3023419) Bacteria identified in Sputum by Culture

416

1.08

0.17

3.7

2.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

395

4039

0.98

0.17

2.8

2.7

—

(3018001) Oat IgE Ab [Units/volume] in Serum

0.75

0.17

1.0

—

0.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

215

0.88

0.16

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

215

0.88

0.16

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

215

0.88

0.16

1.6

—

(4024509)

427

1.08

0.16

1.6

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.16

0.16

1.4

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

360

0.92

0.16

1.1

miu/ml

1383.4

1535.5

0.37

360

(3043238) Trisomy 21 risk [Likelihood] in Fetus

302

3095

0.97

0.16

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

271

2781

0.97

0.15

1.7

1.6

mg/l

2.9

3.5

0.85

185

1922

(3009871) Measles virus Ab [Titer] in Serum

235

1.11

0.15

1.7

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

545

1.06

0.15

1.5

1.3

umol/l

5.2

5.4

0.14

515

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

0.77

0.15

1.3

1.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

925

9367

0.99

0.15

1.6

pmol/l

64453090.6

31407842.6

0.71

813

8100

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

332

1.08

0.15

1.1

—

(44806071)

102

1.18

0.15

1.0

1.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

306

0.91

0.14

1.6

1.2

42.1

70.4

—

(3036048) Francisella tularensis Ab [Titer] in Serum

112

1.16

0.14

1.0

1.1

—

213.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

130

1347

0.96

0.14

1.1

u/ml

0.5

1.5

1.77

326

(40765089) Chromosome analysis panel - Blood by G-banded

212

0.90

0.14

1.1

1.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

666

1.05

0.13

1.2

1.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

315

1.08

0.13

1.1

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

325

1.08

0.13

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

325

1.08

0.13

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

325

1.08

0.13

1.5

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

107

0.84

0.13

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

107

0.84

0.13

1.0

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

242

0.91

0.13

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

200

1.10

0.12

2.6

2.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

528

0.95

0.12

1.0

u/ml

0.4

0.8

0.77

117

(3008295) Osmolality of Serum or Plasma

405

1.06

0.11

1.3

1.6

mosm/kgh2o

278.4

279.7

0.12

320

(3044927) Protein electrophoresis panel - Urine

259

1.08

0.11

1.0

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

386

1.06

0.11

1.4

1.5

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

435

1.06

0.11

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

318

1.07

0.11

1.1

1.0

91.7

92.5

0.06

259

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

157

0.89

0.11

1.3

2.6

—

(3034770) Mitochondria Ab [Titer] in Serum

148

1440

1.03

0.11

1.3

titre

773.8

956.4

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

289

1.07

0.11

1.5

1.6

nmol/l

1.8

3.3

0.94

233

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

167

0.90

0.10

1.1

1.3

u/l

217.0

370.1

2.22

160

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

672

1.04

0.10

1.1

—

22.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

106

1027

1.03

0.10

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

251

1.08

0.10

1.2

1.5

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.14

0.10

3.4

2.8

—

(40768793) Breast Pathology biopsy report

183

1790

1.02

0.10

1.3

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

971

0.97

0.10

1.1

u/ml

0.0

0.3

1.02

188

(3022475) Manganese [Moles/volume] in Blood

1.11

0.09

1.0

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

359

1.06

0.09

1.5

1.6

31.2

40.6

0.88

197

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.09

0.09

1.2

1.4

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

202

1979

1.02

0.09

1.1

u/ml

8.5

5.3

0.22

316

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

203

1.08

0.09

1.0

1.1

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

1.11

0.09

2.3

2.4

pmol/l

54.6

42.9

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

1.09

0.08

1.2

—

2.3

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.07

0.08

1.0

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

461

0.95

0.08

1.3

1.2

u/l

45.7

19.6

0.40

405

(3012494) Peanut IgE Ab [Units/volume] in Serum

216

0.93

0.08

1.2

1.1

u/ml

0.2

2.7

1.50

112

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

0.79

0.08

1.4

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.09

0.08

2.0

2.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.09

0.08

1.4

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

332

1.05

0.08

1.8

1.4

u/l

5.3

5.1

0.19

292

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1.08

0.08

1.0

1.2

—

1.6

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.06

0.08

1.1

1.2

—

(3010937) Rubella virus Ab [Presence] in Serum

1.06

0.08

1.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

105

1077

0.97

0.07

2.0

1.9

ug/l

1.1

1.9

0.93

945

(3048879) Bone marrow aspiration report

0.86

0.07

1.3

2.3

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

1.12

0.07

2.9

1.9

e6/l

903.2

27358.5

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

0.81

0.07

1.0

1.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

146

1431

1.02

0.07

3.3

2.8

mmol/l

25.8

25.4

0.82

140

1375

(3050129) First trimester maternal screen panel - Serum or Plasma

446

4506

0.99

0.07

1.4

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

194

0.93

0.07

1.1

1.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

154

1511

1.02

0.07

2.0

2.2

umol/l

4.7

5.0

0.19

116

1102

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

245

0.94

0.07

1.0

1.1

101.4

96.0

0.57

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

669

1.03

0.07

1.0

1.1

—

89.6

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

118

1.10

0.07

4.6

4.3

—

(3017509) Phencyclidine [Presence] in Urine

1.02

0.07

2.7

1.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

103

1054

0.98

0.06

1.1

—

(4133840)

128

1.09

0.06

1.1

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

177

1.07

0.06

1.1

1.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

100

0.90

0.06

1.0

1.4

—

(3037556) Urate [Mass/volume] in Serum or Plasma

102

0.88

0.06

1.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

503

1.03

0.06

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

830

1.02

0.06

1.4

1.3

nmol/l

1.1

1.3

1.58

678

(3019060) Gas panel - Arterial blood

192

1946

0.99

0.05

5.6

4.6

—

(44813793)

504

1.03

0.05

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

649

6530

0.99

0.05

1.4

1.6

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

212

0.94

0.05

1.4

e6/l

14628.7

83348.5

1.04

114

(3006184) Hemoglobin [Mass/volume] in Capillary blood

812

1.02

0.05

1.7

2.0

g/l

127.9

130.2

0.47

595

(3051593) INR in Capillary blood by Coagulation assay

110

0.91

0.05

1.0

7.5

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

396

1.04

0.05

1.6

1.7

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

137

1349

1.02

0.05

1.1

u/ml

0.5

1.0

1.33

534

(3015183) Erythrocyte sedimentation rate

404

0.97

0.05

1.3

1.2

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

248

1.05

0.05

1.2

109.1

110.1

0.05

220

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

189

1.06

0.04

1.2

16.8

10.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

575

1.03

0.04

1.1

—

(3042517) Benzodiazepines panel - Urine

1.10

0.04

5.6

2.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

104

1057

0.98

0.04

1.4

mmol/l

7.0

6.8

0.24

755

(3020650) Glucose [Presence] in Urine

160

1.06

0.04

2.1

1.5

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

271

0.96

0.04

1.2

g/l

0.3

0.10

218

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

190

0.95

0.04

1.1

1.0

—

(21491868) Cryoglobulin [Mass/volume] in Serum

190

0.95

0.04

1.2

g/l

—

0.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

319

1.03

0.03

1.1

1.3

—

(3012441) Differential panel - Pleural fluid

201

1.04

0.03

1.5

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

350

1.03

0.03

1.3

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

460

1.02

0.02

1.6

1.5

—

(3026470) Cobalt [Mass/volume] in Blood

142

1.06

0.02

2.7

2.0

ug/l

2.9

3.1

0.11

127

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

319

0.97

0.02

1.9

u/field

2.7

2.0

0.32

160

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

172

1.05

0.02

1.1

1.4

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

981

0.99

0.02

3.3

2.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

411

1.02

0.02

1.6

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

133

1.05

0.01

1.4

1.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

159

1600

0.99

0.01

1.2

—

(3003694) ABO and Rh group [Type] in Blood

1697

16983

1.00

0.01

1.6

1.7

—

(1002224) Polysomnography panel

255

2558

1.00

0.01

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

104

1.06

0.01

1.5

1.6

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

112

1113

1.01

0.00

1.1

u/ml

2.7

3.1

0.17

618

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

154

1.04

0.00

1.0

1.1

nmol/l

5.3

0.01

144

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

234

1.03

0.00

1.5

1.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

436

0.99

0.00

1.2

1.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

135

1.04

0.00

2.2

2.3

—

(3029075) Extractable nuclear Ab panel - Serum

175

0.97

0.00

1.0

1.1

—

(3045788) Cell count panel - Pleural fluid

195

0.97

0.00

1.4

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

195

1.03

0.00

1.1

u/ml

64.3

51.4

0.44

189

(3036071) Salmonella sp Ab [Titer] in Serum

205

1.02

0.00

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

465

0.99

0.00

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

144

0.97

0.00

3.1

1.9

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

184

0.98

0.00

1.5

1.6

u/l

13.4

11.6

0.37

177

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

103

0.97

0.00

1.3

1.2

—

(3000012) Reticulocyte production index

183

0.98

0.00

1.1

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

307

1.01

0.00

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

487

1.01

0.00

1.0

u/ml

0.3

—

(3001556) Androgen free Index in Serum or Plasma

1.01

0.00

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

953

1.00

0.00

3.4

mg/l

15.9

23.0

2.19

579

(3023199) Leukocytes [#/volume] in Pleural fluid

241

1.00

0.00

1.3

1.4

e6/l

18573.1

2822.5

0.46

170

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

168

1681

1.00

0.00

9.1

8.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

191

1911

1.00

0.00

7.7

6.4

mmol/l

24.7

24.4

0.54

178

1775

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.85

0.00

1.8

7.2

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

1.0

—

1.1

—

(3051671) S100 calcium binding protein B [Mass/volume] in Serum

0.00

0.0

2.0

—

0.2

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.7

—

611.3

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

0.88

0.00

1.6

2.2

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

3.4

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

5.8

—

359.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

143

1430

1.00

0.00

1.1

u/ml

4.6

5.1

0.17

722

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

200

1.00

0.00

2.5

2.1

ug/l

1.7

1.2

0.45

189

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

0.90

0.00

1.7

2.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.92

0.00

1.2

—

(3012932) Hazelnut IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

6.4

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

0.0

1.0

—

308.8

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

0.00

0.0

1.0

—

(40757373) Influenza virus identified in Isolate

0.96

0.00

1.7

1.5

—

(3014271) Vancomycin [Susceptibility]

0.91

0.00

2.3

2.9

—

(3016330) Potassium [Moles/time] in 24 hour Urine

1.01

0.00

1.1

1.3

—

99.5

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

0.94

0.00

1.2

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.90

0.00

1.0

1.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.95

0.00

1.4

1.1

—

(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid

0.00

0.0

5.1

—

1.2

—

(36303858) Crystals [Presence] in Urine

0.00

0.0

1.2

—

(3035880) pH of Pleural fluid

100

1.00

0.00

1.0

1.2

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.0

1.0

—

(40758292) HTLV I+II Ab panel - Serum

1.00

0.00

1.3

1.4

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.89

0.00

1.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint N14_FEMALE_GENITAL_LSIL and mortality.

Females

Parameter	HR [95% CI]	p-value
N14_FEMALE_GENITAL_LSIL	1.019 [0.91, 1.15]	0.75
Birth year	0.991 [0.98, 1.0]	0.052

During the follow-up period (1.1.1998 — 31.12.2019), 1028 out of 27266 females with N14_FEMALE_GENITAL_LSIL died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have N14_FEMALE_GENITAL_LSIL.

N-year risk	Females	Males
1	0.107%	No data
5	0.611%	No data
10	1.459%	No data
15	2.814%	No data
20	4.773%	No data

Relationships between endpoints

↥

Index endpoint: N14_FEMALE_GENITAL_LSIL – LSIL lesion of the cervix uteri, vagina or vulva

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

LSIL lesion of the cervix uteri, vagina or vulva

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints